Biogen Inc. (NASDAQ:BIIB) is one of the top cheap pharmaceutical stocks to buy now. BofA lowered the firm’s price target on Biogen Inc. (NASDAQ:BIIB) to $142 from $143 on August 1, keeping a Neutral ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the May 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

May 05, 2025 — 10:20 am EDT Written by Quiver ForecastTracker for Quiver Quantitative -> ...

If an investor was to purchase shares of BIIB stock at the current price level of $261.97/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the April 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

Our analysis of options history for Biogen (NASDAQ: BIIB) revealed 12 unusual trades. Delving into the details, we found 25% of traders were bullish, while 66% showed bearish tendencies.

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the July 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Biogen Inc (Symbol: BIIB), where a total of 11,859 contracts have traded so far ...

In recent trading, shares of Biogen Inc (Symbol: BIIB) have crossed above the average analyst 12-month target price of $247.28, changing hands for $276.61/share. When a stock reaches the target an ...

In early trading on Thursday, shares of Biogen (BIIB) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.3%. Year to date, Biogen registers a 10.3% gain.